Abstract Menkes disease is an X-linked recessive disorder of the copper membrane transport system caused by mutations in the ATP7A gene. While various mutations in the ATP7A gene have been reported, a genotype-phenotype correlation has not been clearly defined. A novel mutation in the ATP7A gene in a Japanese patient with classical Menkes disease was identified via analysis of reversetranscriptase polymerase chain reaction products and genomic DNA of the ATP7A gene. The nonsense mutation, L718X, was found to result in premature termination and immature ATP7A protein, unlikely to have normal functioning. Therefore, this nonsense mutation of the ATP7A gene is proposed to play a causative role in presenting the classical Menkes phenotype. Furthermore, four novel polymorphisms, C1535T (L464L), C2151T (T669I), G2253A (R703H), and C3677T (H1178Y) were also identified.
Introduction
Menkes disease (OMIM 309400) is an X-linked recessive disorder of copper transport, characterized by neurodegeneration in infancy, failure to thrive, and abnormalities of the connective tissues (Menkes et al. 1962) . The Menkes gene (ATP7A, previously designated as MNK) codes for a protein predicted to be a P-type cation-transporting adenosine triphosphatase (ATPase) (Chelly et al. 1993; Mercer et al. 1993; Vulpe et al. 1993) , due to homology with a bacterial form and the presence of a putative metalbinding motif at the N-terminus (Vulpe et al. 1993) . The clinical spectrum of Menkes disease includes a range of neurological severity from the classical type to the occipital horn syndrome. Although various authors (Das et al. 1994; Ogawa et al. 1999a; Tümer et al. 1997) have found mutations in the ATP7A gene obtained from patients with Menkes disease, a genotype-phenotype correlation has not been clearly defined. Thus, it is important to characterize and report any mutations found in this devastating illness.
The purpose of this study was to explore the presence of mutation in the ATP7A gene in a Japanese patient with classical Menkes disease.
Subjects and methods

Subjects
The patient, aged 8 years, was a Japanese boy who was the second child of a healthy, unrelated couple, a 34-year-old father and a 33-year-old mother. The elder sister of the patient was healthy. The patient was vaginally delivered at 37 weeks' gestation after an unremarkable pregnancy, with a birth weight of 2804 g. At birth, he had kinky hair and showed hypotonia, convulsions, and hypothermia. His serum level of copper was 45 µg/dl, and the ceruloplasmin level was 13 mg/dl. The diagnosis of Menkes disease was made on the basis of these clinical and laboratory findings. Once informed consent was obtained, genomic DNA samples were extracted from the peripheral blood of the patient and from 104 healthy unrelated Japanese volunteers, to assess the allelic frequencies and polymorphisms of the ATP7A gene.
DNA sequencing and electrophoresis
Peripheral leukocytes were used for poly Aϩ RNA isolation. The 4.5-kb coding region (Vulpe et al. 1993 ; GenBank accession number NM 000052) was divided into four over-lapping segments and each segment was amplified by reverse-transcriptase polymerase chain reaction (RT-PCR). The number of nucleotides present in each of the segments was: segment 1, 106-1308; segment 2, 1088-2450; segment 3, 2330-3608; and segment 4, 3438-4758. Amplified segments were cloned into pGEM-T Easy Vector (Promega, Madison, WI, USA) and sequenced using an automated DNA sequencer (DSQ 2000L; Shimadzu, Kyoto, Japan). The identified mutation was confirmed by sequencing of the genomic DNA.
The PCR products amplifying the mutation-bearing exon were digested with Mse I and then subjected to electrophoresis on 3% NuSieve 3 :1 agarose gels (FMC BioProducts, Rockland, ME, USA).
Polymorphisms
For assessment of the allelic frequencies of the ATP7A gene in the Japanese population, restriction enzyme analysis was performed. The G2253A polymorphism is known to remove the Hha I site, while the G2444C polymorphism removes the Bfa I site. None of the other three of five nucleotide changes, C1535T, C2151T, and C3677T, result in modification of the restriction sites of the ATP7A gene. Additional base substitutions were therefore artificially introduced into the region of each nucleotide change site. For the C1535T, an artificial Mse I site (TTAA; the substitution in the primer sequence is underlined and C1535T is shown in bold type) was introduced into the T1535 sequence, but not into the C1535 sequence. For the C2151T, an artificial Eco RV site (GATATC; formatting conventions as above; C2151T is shown in bold type) was introduced into the T2151 sequence, but not into the C2151 sequence. For the C3677T, an artificial Acc I site (GTATAC; formatting conventions as above; C3677T is shown in bold type) was introduced into the T3677 sequence, but not into the C3677 sequence. The PCR products were digested with the appropriate restriction enzymes and then electrophoresed.
Results and discussion
DNA sequencing
The four RT-PCR products amplified from ATP7A cDNA were normal in size. Each fragment was cloned and sequenced. A nonsense mutation, T2298A (L718X), was found in segment 2. Genomic analysis of exon 9 of the ATP7A gene, which contains the nucleotide at position 2298, confirmed the presence of this mutation (Fig. 1) . The mutation leads to premature termination at codon 718, resulting in an immature ATP7A protein, unlikely to have normal functioning. Therefore, we propose that this nonsense mutation could confer the observed disease state.
Carrier diagnosis
Carrier diagnosis was performed in the patient's mother and sister via extraction of genomic DNA from leukocytes and amplification of the mutation-bearing exon. Analysis of Mse I-digested PCR products indicated that the mutation was maternally inherited (Fig. 2) . The sister of the patient was found not to carry the mutation. A prenatal molecular-genetic diagnosis may therefore be possible in this family. Fig. 2 . T2298A carrier analysis. The Mse I digestion of the polymerase chain reaction (PCR) product from the genomic DNA of a normal control generated one DNA fragment of 612-bp (lane 1). The mutation, T2298A, generated a second Mse I site. The Mse I digestion of the PCR product from the patient generated two DNA fragments, of 562-and 50-bp (lane 4). The Mse I digestion of the PCR product from the mother generated a DNA fragment of 612-bp derived from a normal allele that lacks the Mse I site, in addition to the 562-and 50-bp fragments (lane 2). This result indicates that the mother is heterozygous for the T2298A mutation. The result of the Mse I digestion of the PCR product from the sister was the same as that in the control, indicating that the sister is not carrying the T2298A mutation. The 50-bp fragment is not shown in this Fig. M, 100- (Das et al. 1994; Ogawa et al. 1999b ) ( Table 1 ). The nucleotide changes C1535T, C2151T, and C3677T were observed in the patient and the three controls. The nucleotide change G2253A was observed in one of the three normal controls. Each of these nucleotide changes is considered to be a polymorphism rather than a mutation, in accordance with one of the following criteria: (a) does not affect the amino acid sequence of the protein product; (b) results in conservative changes in apparently non-vital residues within the protein; or (c) is present on normal chromosomes in the population (Thomas et al. 1995) . While five of the identified polymorphisms (C2151T, G2253A, C3677T, G2444C, and A4535G) cause an amino acid substitution, prediction analysis, using the Chou-Fasman method, suggests that these nucleotide changes would be unlikely to modify the secondary structure of the product.
To investigate the allelic frequencies in the normal Japanese population, restriction enzyme digestion analysis was performed. Table 1 shows a summary of the frequencies of the polymorphisms observed. The nucleotide changes C1535T, C2151T, and C3677T were found in all Japanese individuals tested, and thus are believed to be due to ethnic variation.
In summary, we have identified a novel mutation in the ATP7A gene in a patient with classical Menkes disease. Further analysis of more patients may be necessary to elucidate the relationship between the genotype and the phenotype. 
